Live from the NIH registry
Studies recruiting near Lansing right now
Top 25 of 174 recruiting studies, sorted by proximity — each links to its official registry page
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Sepsis, Systemic Inflammatory Response Syndrome
N/A
Observational 2,500 participants sought
University of Michigan Health/Sparrow (name change only) — Lansing, Michigan (1.3 mi)
· Sponsor: Michigan State University
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
Parkinson Disease, Atypical Parkinsonism
N/A
Interventional 100 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Lansing, Michigan (1.3 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
MSU Center for Bleeding and Clotting Disorders — Lansing, Michigan (1.3 mi)
· Sponsor: American Thrombosis and Hemostasis Network
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Narcolepsy Type 2
Phase 3
Interventional 176 participants sought
Alkermes Investigational Site — Lansing, Michigan (1.3 mi)
· Sponsor: Alkermes, Inc.
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Phase 3
Interventional 750 participants sought
Barbara Ann Karmanos Cancer Institute — Lansing, Michigan (1.3 mi)
· Sponsor: Amgen
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
Pregnancy
N/A
Interventional 4,700 participants sought
Planned Parenthood - Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: University of Michigan
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Recurrent
N/A
Interventional 198 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Lansing, Michigan (1.3 mi)
· Sponsor: Medtronic
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: American Society of Clinical Oncology
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Lansing, Michigan (1.3 mi)
· Sponsor: Massive Bio, Inc.
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Sparrow Clinical Research Institute — Lansing, Michigan (1.3 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Lansing, Michigan (1.3 mi)
· Sponsor: Medtronic
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: National Cancer Institute (NCI)
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Novo Nordisk A/S
Ask Questions About Clinical Trials
Oncology, Cardiac Disease
N/A
Interventional 293 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
Reducing Lead Dust Exposure in Older Housing
Exposure to Toxic Dust, Elevated Blood Lead Levels
N/A
Interventional 40 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: PedAL BCU, LLC
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Treating Chronic Cervicogenic Head and Neck Pain
Cervicogenic Headache, Neck Pain, Posterior
Phase 1, Phase 2
Interventional 30 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University